Hsu, P.-C.; Wang, C.-W.; Kuo, S.C.-H.; Lin, S.-M.; Lo, Y.-L.; Huang, A.C.-C.; Chiu, L.-C.; Yang, C.-T.
The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma. Biomedicines 2020, 8, 36.
https://doi.org/10.3390/biomedicines8020036
AMA Style
Hsu P-C, Wang C-W, Kuo SC-H, Lin S-M, Lo Y-L, Huang AC-C, Chiu L-C, Yang C-T.
The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma. Biomedicines. 2020; 8(2):36.
https://doi.org/10.3390/biomedicines8020036
Chicago/Turabian Style
Hsu, Ping-Chih, Chih-Wei Wang, Scott Chih-Hsi Kuo, Shu-Min Lin, Yu-Lun Lo, Allen Chung-Cheng Huang, Li-Chung Chiu, and Cheng-Ta Yang.
2020. "The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma" Biomedicines 8, no. 2: 36.
https://doi.org/10.3390/biomedicines8020036
APA Style
Hsu, P.-C., Wang, C.-W., Kuo, S. C.-H., Lin, S.-M., Lo, Y.-L., Huang, A. C.-C., Chiu, L.-C., & Yang, C.-T.
(2020). The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma. Biomedicines, 8(2), 36.
https://doi.org/10.3390/biomedicines8020036